AR034505A1 - Composiciones medicinales y proceso de manufactura - Google Patents
Composiciones medicinales y proceso de manufacturaInfo
- Publication number
- AR034505A1 AR034505A1 ARP020102257A ARP020102257A AR034505A1 AR 034505 A1 AR034505 A1 AR 034505A1 AR P020102257 A ARP020102257 A AR P020102257A AR P020102257 A ARP020102257 A AR P020102257A AR 034505 A1 AR034505 A1 AR 034505A1
- Authority
- AR
- Argentina
- Prior art keywords
- manufacture process
- medicinal compositions
- core
- film
- weight
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Una composición medicinal que comprende: (a) un núcleo que comprende una dosis unitaria medicinalmente efectiva de 1 o más medicamentos activos; y (b) estando dicho(s) medicamento(s) encapsulado(s) en el interior de un material en forma de película que comprende por lo menos un 40% por peso de hidroxipropilmetil celulosa.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0114746.1A GB0114746D0 (en) | 2001-06-16 | 2001-06-16 | Medicinal composition |
Publications (1)
Publication Number | Publication Date |
---|---|
AR034505A1 true AR034505A1 (es) | 2004-02-25 |
Family
ID=9916758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020102257A AR034505A1 (es) | 2001-06-16 | 2002-06-14 | Composiciones medicinales y proceso de manufactura |
Country Status (11)
Country | Link |
---|---|
US (1) | US7780977B2 (es) |
EP (1) | EP1401403B1 (es) |
AR (1) | AR034505A1 (es) |
AT (1) | ATE355831T1 (es) |
AU (1) | AU2002304418A1 (es) |
DE (1) | DE60218671T8 (es) |
DK (1) | DK1401403T3 (es) |
ES (1) | ES2283558T3 (es) |
GB (1) | GB0114746D0 (es) |
PT (1) | PT1401403E (es) |
WO (1) | WO2002102356A2 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL130602A0 (en) | 1999-06-22 | 2000-06-01 | Dexcel Ltd | Stable benzimidazole formulation |
GB0229258D0 (en) * | 2002-12-16 | 2003-01-22 | Boots Healthcare Int Ltd | Medicinal compositions |
CN103284929B (zh) * | 2012-02-23 | 2015-08-12 | 黄曦 | 一种护肤品及其制备方法 |
GB2507522B (en) * | 2012-11-01 | 2014-12-31 | Cosmetic Warriors Ltd | Solid cosmetic composition |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2030042A (en) * | 1978-09-21 | 1980-04-02 | Beecham Group Ltd | Antacid fondant |
US4684534A (en) * | 1985-02-19 | 1987-08-04 | Dynagram Corporation Of America | Quick-liquifying, chewable tablet |
US4931285A (en) * | 1988-04-28 | 1990-06-05 | Alza Corporation | Aqueous based pharmaceutical coating composition for dosage forms |
IE71202B1 (en) | 1990-12-17 | 1997-02-12 | Akzo Nv | Progestagen-only contraceptive |
GB9606371D0 (en) * | 1996-03-26 | 1996-06-05 | Brown Malcolm D | An encapsulation process |
FR2750859B1 (fr) | 1996-07-12 | 1999-01-22 | Maurel Sante | Composition pharmaceutique destinee a une administration par voie buccale avec absorption d'au moins un principe actif a travers les muqueuses de la bouche |
CN1203792A (zh) | 1997-06-02 | 1999-01-06 | 张志宏 | 复方聚维酮碘口含片 |
CN1183904C (zh) * | 1999-02-26 | 2005-01-12 | 盐野义制药株式会社 | 改进了服用性的咀嚼型软胶囊剂及其制法 |
DE19922537A1 (de) | 1999-05-10 | 2000-11-16 | Roland Bodmeier | Darreichungsform zur Applikation in Körperöffnungen |
-
2001
- 2001-06-16 GB GBGB0114746.1A patent/GB0114746D0/en not_active Ceased
-
2002
- 2002-06-11 AU AU2002304418A patent/AU2002304418A1/en not_active Abandoned
- 2002-06-11 PT PT02732927T patent/PT1401403E/pt unknown
- 2002-06-11 AT AT02732927T patent/ATE355831T1/de not_active IP Right Cessation
- 2002-06-11 EP EP02732927A patent/EP1401403B1/en not_active Expired - Lifetime
- 2002-06-11 ES ES02732927T patent/ES2283558T3/es not_active Expired - Lifetime
- 2002-06-11 WO PCT/GB2002/002637 patent/WO2002102356A2/en active IP Right Grant
- 2002-06-11 US US10/481,056 patent/US7780977B2/en not_active Expired - Fee Related
- 2002-06-11 DK DK02732927T patent/DK1401403T3/da active
- 2002-06-11 DE DE60218671T patent/DE60218671T8/de active Active
- 2002-06-14 AR ARP020102257A patent/AR034505A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002102356A3 (en) | 2003-03-06 |
DE60218671T8 (de) | 2008-08-21 |
EP1401403A2 (en) | 2004-03-31 |
US20050042276A1 (en) | 2005-02-24 |
ES2283558T3 (es) | 2007-11-01 |
WO2002102356A2 (en) | 2002-12-27 |
EP1401403B1 (en) | 2007-03-07 |
DE60218671T2 (de) | 2007-11-15 |
DK1401403T3 (da) | 2007-07-09 |
PT1401403E (pt) | 2007-05-31 |
US7780977B2 (en) | 2010-08-24 |
ATE355831T1 (de) | 2007-03-15 |
GB0114746D0 (en) | 2001-08-08 |
DE60218671D1 (de) | 2007-04-19 |
AU2002304418A1 (en) | 2003-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MEP36608A (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
AR035927A1 (es) | Compuesto de lactama (n)-((s)-2-hidroxi-3-metilbutiril)-1-(l-alaninil)-(s)-1-amino-3-metil-4,5,6,7-tetrahidro-2h-3-benzazepin-2-ona , composicion farmaceutica que lo comprende, procedimiento para la inhibicion de la liberacion de peptido b-amiloide y/o su sintesis que lo emplea y su uso para la fabr | |
ECSP003835A (es) | Composicion para dosis oral de liberacion extendida | |
MX2007006212A (es) | Medicamento oral para liberacion modificada de al menos un principio activo bajo forma multimicrocapsular. | |
ES2062392T3 (es) | Medicamentos que comprenden salmeterol y fluticasona. | |
ES2178430T3 (es) | Utilizacion de composiciones farmaceuticas gelificables en parodontologia. | |
AR013506A1 (es) | Uso de una composicion farmaceutica para la manufactura de un medicamento para ser usado en el tratamiento de enfermedades de obstruccion pulmonarcronica y de un kit que comprende formoterol o una sal o solvato del mismo y budesonida | |
BR0015605A (pt) | Composição e uso | |
BR0209366A (pt) | Cápsulas de inalação | |
AR002754A1 (es) | Composición farmacéutica que comprende bacterias lactobacillus viables micro-encapsuladas, y uso de la composición para preparar de un medicamento | |
CR8352A (es) | Formulaciones farmaceuticas, procedimientos y pautas de dosificacion para el tratamiento y prevencion de sindromes coronarios agudos | |
AR065970A2 (es) | Una composicion farmaceutica oral solida que comprende una combinacion de metformin y glibenclamida y uso de dicha composicion | |
UY27533A1 (es) | Composiciones farmacéuticas que contienen oxibutinina | |
BR0015188A (pt) | Composições farmacêuticas | |
UY24613A1 (es) | Formula de liberacion controlada que comprende venlafaxina | |
AR035533A1 (es) | Uso de por lo menos un inhibidor de la absorcion de los esteroles o sus sales, solvatos, prodrogas farmaceuticamente aceptables o mezclas de los mismos para la preparacion de un medicamento para el tratamiento de la sitosterolemia, composiciones farmaceuticas, el uso de dichas composiciones para la | |
ATE339187T1 (de) | Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt | |
BRPI0411986A (pt) | forma de dosagem farmacêutica multiparticulada, contendo substáncias peptìdicas ou protéicas ativas formuladas de maneira mucoadesiva, e um método para produzir a dita forma de dosagem farmacêutica | |
ES2181417T3 (es) | Formulacion de capsulas o tabletas de efavirenz de disolucion rapida usando super-desintegrantes. | |
ATE430557T1 (de) | Liposomen | |
RS50937B (sr) | Farmaceutska kompozicija koja sadrži metformin i glibenklamid za lečenje šećerne bolesti tipa ii | |
UY25234A1 (es) | Formulación de liberación prolongada de venlafaxina | |
EE04997B1 (et) | Loteprednooli ja antihistamiinseid aineid sisaldav farmatseutiline kompositsioon, neid aineid sisaldav ravim, meetod selle ravimi valmistamiseks ja nende ainete kombinatsiooni kasutamine | |
BRPI0512241A (pt) | inalador utilizando casulos | |
HK1068606A1 (en) | Novel aminobenzoephenones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |